Registry of Vaccine Responses in Immune Compromised Patients
Laure Pittet, MD-PhD
300 participants
Sep 24, 2024
OBSERVATIONAL
Conditions
Summary
The aim of this project is to monitor, guide and document vaccination, vaccine responses, persistence of protection, vaccine efficacy and safety in immune compromised patients at various moment of their disease: right after the diagnosis, before the introduction of the immunosuppressive treatment, once the individual is under immunosuppressive treatment, or once immunosuppression is over.
Eligibility
Inclusion Criteria2
- Immune compromised patient or patient who will soon be immunocompromised
- Informed consent as documented by signature
Exclusion Criteria2
- Individual/parental inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, known/suspected non-compliance, substance abuse, etc.
- Plan to move out of the country or have prolong absence in the next 2 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The aim of this observational project is to document the immunogenicity and reactogenicity of vaccines given to immunocompromised patients and collect it in a registry.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06463119